InvestorsHub Logo
Followers 2
Posts 429
Boards Moderated 0
Alias Born 07/13/2016

Re: TheBioTechG post# 16393

Friday, 08/04/2017 1:48:23 PM

Friday, August 04, 2017 1:48:23 PM

Post# of 233457
Combo revenues depends on the label the FDA would give the company. If it is just the salvage market, there will not be many revenues at all. If they allow PRO 140 to be used higher up the chain, the impact could be very, very significant. The label will be another binary event with huge implications for the stock when/if it gets there.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News